NANOS KNOCK-OUT THAT ABLATES GERMLINE CELLS

SKIN TISSUE

TRANSGENIC ANIMALS AND RECOMBINANT HOST CELLS COMPRISING SPECIFIC GENE VARIANTS AND METHODS OF CREATING SAME

GENETICALLY MODIFIED MOUSE FOR PREPARING ANTIBODY AND METHOD FOR PREPARING GENETICALLY MODIFIED MOUSE

GENE THERAPY

GENETICALLY MODIFIED MOUSE FOR PREPARING ANTIBODY AND METHOD FOR PREPARING GENETICALLY MODIFIED MOUSE

METHODS FOR PRODUCING ANTIBODIES

NON-HUMAN ANIMALS COMPRISING A MODIFIED TRANSFERRIN RECEPTOR LOCUS

GENETIC COMPLEMENTATION COMPOSITIONS AND METHODS

CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE

MEASURING THE PROGRESS OF CARDIAC XENOGRAFT IMMUNE REJECTION

ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION

Mouse Model For Alzheimer's Disease And Neurofibrillary Pathology

GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS FOR PRODUCING HEAVY-CHAIN ANTIBODIES

AGENT FOR DETECTING STRUCTURALLY ABNORMAL PROTEIN AND AGENT FOR REDUCING STRUCTURALLY ABNORMAL PROTEIN

COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR

CONSTRUCTION METHOD AND USE OF Thy1-SNCA; Clu GENE KNOCKOUT MOUSE MODEL

MOUSE MODEL FOR RETINA DEGENERATION AND USES THEREOF

AAVR KNOCKOUT MOUSE IN COMBINATION WITH HUMAN LIVER CHIMERISM AND METHODS OF USE AND PRODUCTION OF THE SAME

COMMON LIGHT CHAIN MOUSE

MOUSE MODELS OF CYTOKINE RELEASE SYNDROME

CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE

ANIMAL MODEL OF TDP-43 PROTEINOPATHY

METHODS FOR TREATING LYSOSOMAL STORAGE DISEASES

METHOD FOR PROMOTING SEXUAL MATURATION OF FISH

DNA EDITING USING SINGLE-STRANDED DNA

ANIMAL MODELS AND METHODS OF USE

METHOD OF GENETIC MANIPULATION OF NEURAL CELLS IN GYRENCEPHALIC FETAL BRAIN AND USES THEREOF

COMPOSITIONS AND METHODS FOR MYOSIN HEAVY CHAIN BASE EDITING

COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT

REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION

METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS

TRANSGENIC ANIMAL HAVING MODIFIED MYOSTATIN GENE

HUMAN LIVER CHIMERIC NON-HUMAN ANIMAL WITH DEFICIENT P450 OXIDOREDUCTASE AND METHODS OF USING SAME

VECTORS, GENETICALLY MODIFIED CELLS, AND GENETICALLY MODIFIED NON-HUMAN ANIMALS COMPRISING THE SAME

GENETICALLY MODIFIED NON-HUMAN MAMMALS, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF

GENE THERAPY FOR HAPLOINSUFFICIENCY

VIABLE GALACTOSYLTRANSFERASE KNOCK-OUT SHEEP AND RELATED METHODS

PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED CD163 GENES

IMMUNODEFICIENT FCGR1 KNOCKOUT MOUSE MODELS

COMPOSITIONS AND METHODS FOR DEFINING OPTIMAL TREATMENT TIMEFRAMES IN LYSOSOMAL DISEASE

BMX MOUSE MODELS FOR BECKER MUSCULAR DYSTROPHY (BMD) V

TELOMERASE REVERSE TRANSCRIPTASE THERAPY FOR KIDNEY FIBROSIS AND NON-HUMAN ANIMALS THEREOF

THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH

BRAIN TUMOR MODEL

FISH, METHOD FOR PRODUCING FISH, AND METHOD FOR PRODUCING FISH EXHIBITING ACCELERATED MATURATION

METHOD FOR PRODUCING STERILIZED MALE INDIVIDUALS OF MARINE FISH, METHOD FOR PREVENTING REPRODUCTION OF MARINE FISH, AND STERILIZED MALE INDIVIDUALS OF MARINE FISH

METHODS FOR IDENTIFYING AND USING ALLOGENEIC TUMOR INFILTRATING LYMPHOCYTES TO TREAT CANCER

GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES

TRIPLE TRANSGENIC PIGS SUITABLE FOR XENOGRAFT

GENETICALLY MODIFIED MOUSE MODELS AND METHODS OF USE THEREOF

METHOD AND DEVICE FOR DRUG SCREENING

GENETICALLY MODIFIED MICE FOR PREPARING ANTIBODIES AND PREPARATION METHOD THEREFOR

COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY AND MOTOR BEHAVIOR

TREATMENT OF NUDT2 MUTATION

METHODS FOR GENERATING GENETICALLY MODIFIED ANIMALS

NON-HUMAN ANIMALS COMPRISING A MODIFIED CACNG1 LOCUS

Ethical Tissues for Transplantation

Multiplexed Genome Editing

FEL D 1 KNOCKOUTS AND ASSOCIATED COMPOSITIONS AND METHODS BASED ON CRISPR-CAS9 GENOMIC EDITING

DGAT1/2-INDEPENDENT ENZYME SYNTHESIZING STORAGE LIPIDS (DIESL)

LOW AFFINITY FcyR DEFICIENT MICE

FULL-LENGTH HUMAN ACE2 MOUSE MODEL SUSCEPTIBLE TO EMERGING CORONAVIRUSES

NEURODEGENERATIVE AND AMYOTROPHIC MODEL ANIMAL

NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3

NON-MEIOTIC ALLELE INTROGRESSION

Compositions and methods for treating non-age-associated hearing impairment in a human subject

METHODS FOR MAKING GENETIC EDITS

METHODS OF MODULATING SEX RATIO

TRANSGENIC ANIMAL MODEL, METHOD FOR CONSTRUCTING SAME, AND USE THEREOF

High Efficiency Beef Cattle Having Modified ACTN3 Genes

ANIMAL MODEL FOR DISEASES ASSOCIATED WITH ABSENCE OR REDUCTION OF SOCIAL DOMINANCE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES

Non-Human Animals Expressing Humanized CD3 Complex

METHODS OF TREATING MITOCHONDRIAL DISORDERS

UT2 GENE-DEFICIENT MOUSE MODEL AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR MYELOID LEUKEMIA, USING SAME

INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF

Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant

PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS

ANTIBODY PRODUCTION

SGRNA AND CONSTRUCTING DUAL PIG MODEL OF SEVERE IMMUNODEFICIENCY AND LIVER INJURY AND USE THEREOF

CONTROLLED GENE EXPRESSION METHODS AND MEANS

Method for Constructing Murine Model with Mutations in Csf1r Gene and Application thereof

DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES

Methods of Treating Muscular Dystrophy

Nucleic Acid Molecules Encoding Indoleamine 2,3-Dioxygenase-2

CHARACTERIZING THE BINDING INTERACTIONS BETWEEN MUSK AND BMP RECEPTORS

T CELL REGULATION

GENETICALLY ENGINEERED SWINE FOR PRECLINICAL VALIDATION

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS

GENE THERAPY FOR DENT DISEASE

GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)

Opsins as Chemosensory Receptors and Related Methods

Pathogen-resistant animals having modified CD163 genes

GENE THERAPY FOR DOPAMINE TRANSPORTER DEFICIENCY SYNDROME

Genetically modified non-human having humanized gamma and delta TCR variable genes

REGULATORS OF B CELL-MEDIATED IMMUNOSUPPRESSION

MESENCHYMAL STEM CELLS AND ADIPOCYTES FOR PREPARING MITOKINE MIXTURE, AND THERAPEUTIC OR PROPHYLACTIC DRUG

GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF

RNAi COMPOSITIONS AND METHODS FOR GENERATION OF SINGLE SEX OFFSPRING

CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCE

TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES

LIVESTOCK ANIMALS WITH IMPROVED GROWTH PERFORMANCE

GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO

HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI

Animal Models and Therapeutic Molecules

SIMULATION METHOD FOR CHRONIC ATROPHIC GASTRITIS (CAG) LESION AND IDENTIFICATION METHOD FOR MOUSE MODELING

METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME

PREPARATION METHOD AND APPLICATION OF NON-HUMAN MAMMALS OR THEIR PROGENIES

Compositions and methods for treating non-age-associated hearing impairment in a human subject

DAUGHTERLESS MALE MAMMALS FOR NON-HUMAN POPULATION SUPPRESSION

CRUCIAN CARP (CARASSIUS AURATUS) STRAIN WITHOUT INTERMUSCULAR BONES AND BREEDING METHOD THEREOF

JAK3 GENE-MUTATED, SEVERE COMBINED IMMUNODEFICIENCY ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR

TMPRSS KNOCKOUT SWINE HAVING A REDUCED SUSCEPTIBILITY TO INFLUENZA

USE OF MALIC ENZYME 2 IN PREPARATION OF DIAGNOSTIC REAGENT OR MEDICAMENT FOR SILICOSIS OR PULMONARY FIBROSIS-RELATED DISEASE

Compositions and methods for treating non-age-associated hearing impairment in a human subject

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

MURINE-MHC-DEFICIENT HLA-TRANSGENIC NOD-MOUSE MODELS FOR T1D THERAPY DEVELOPMENT

COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS

ETV2 AND USES THEREOF

A HIGH-THROUGHPUT SCREENING METHOD TO DISCOVER OPTIMAL GRNA PAIRS FOR CRISPR-MEDIATED EXON DELETION

DNA EDITING USING SINGLE-STRANDED DNA

NUCLEASE-MEDIATED REPEAT EXPANSION

HUMAN LIVER CHIMERIC NON-HUMAN ANIMAL WITH DEFICIENT P450 OXIDOREDUCTASE AND METHODS OF USING SAME

ANIMAL MODEL, METHODS FOR MAKING AND USING THEREOF, AND COMPOSITION FOR TREATING ATAXIA

Gene therapy for haploinsufficiency

PRECISE BREEDING METHODS FOR GENE-EDITED NON-HUMAN ANIMALS

MOTOR NEURON-SPECIFIC EXPRESSION VECTORS

Animal Models and Therapeutic Molecules

Method for Constructing Ptgds Gene Knockout Rat Model with Spontaneous Kidney Yin Deficiency

Animal Models and Therapeutic Molecules

IMMUNITY ENHANCING AGENT FOR CANCER BY ALLERGIN-1 ANTAGONIST

ANIMAL MODEL OF BRAIN TUMOR AND MANUFACTURING METHOD OF ANIMAL MODEL

NON-HUMAN ANIMAL MODELS FOR AGING AND/OR NEURODEGENERATION

LINCRNA-DEFICIENT NON-HUMAN ANIMALS

GRNA FOR KNOCKING OUT PIG XENOANTIGEN GENE, AND APPLICATION THEREOF

NON-HUMAN ALZHEIMER'S DISEASE MODEL ANIMAL AND METHOD FOR PRODUCING SAME

MODIFIED SALMON WHICH PRODUCE STERILE OFFSPRING

Viable genetically modified sheep with an inactivated alpha-1,3-galactosyltransferase (GGTA1) gene

METHODS AND COMPOSITIONS FOR TREATMENT OF ATHEROSCLEROSIS

Compositions and methods for treating non-age-associated hearing impairment in a human subject

ANIMAL MODELS OF LIPID METABOLISM AND METHODS OF TREATING HYPERLIPIDEMIA OR HYPERLIPIDEMIA-RELATED DISEASES

METHODS FOR INCREASING THE DIVERSITY OF MONOCLONAL ANTIBODIES PRODUCED AGAINST AN ANTIGEN

GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPa/CD47

NON-HUMAN PRIMATE ALZHEIMER'S DISEASE MODEL ANIMAL AND METHOD FOR PRODUCING SAME

USE OF SYNAPTOTAGMIN-7 IN THE DIAGNOSIS AND TREATMENT OF BIPOLAR DISORDER

ENGINEERED CATFISH AND USES THEREOF

NON-HUMAN ANIMALS HAVING A LIMITED LAMBDA LIGHT CHAIN REPERTOIRE EXPRESSED FROM THE KAPPA LOCUS AND USES THEREOF

APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASE

DONOR PIGS FOR XENOTRANSPLANTATION

DIAGNOSTIC TEST FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS

DRUG TARGET OF IDIOPATHIC PULMONARY FIBROSIS

GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES

ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF

ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN SELECTED NEURONAL CELL POPULATIONS

TRANSGENIC CLONED PIG FOR XENOTRANSPLANTATION EXPRESSING HUMAN CD46 AND TBM GENES, IN WHICH PORCINE ENDOGENOUS RETROVIRUS ENVELOPE C IS NEGATIVE AND GGTA1, CMAH, iGb3s AND ß4GalNT2 GENES ARE KNOCKED OUT, AND METHOD FOR PREPARING SAME

METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION THROUGH SINGLE-STEP MULTIPLE TARGETING

COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOCHROMATOSIS

Rodent Model Of Increased Bone Mineral Density

MULTI-TRANSGENIC PIGS WITH GROWTH HORMONE RECEPTOR KNOCKOUT FOR XENOTRANSPLANTATION

BI-FUNCTIONAL HUMANIZED ANTI-C5 ANTIBODIES AND FACTOR H FUSION PROTEINS AND USES THEREOF

MICE THAT MAKE HEAVY CHAIN ANTIBODIES

Compositions and methods for producing genetically modified animals

NEUROGENESIS

ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION

METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS

GENETIC MODIFICATION OF PIGS FOR XENOTRANSPLANTATION

Genetically modified rat models for severe combined immunodeficiency (SCID)

Targeting Vector, Nucleic Acid Composition, and Method for Constructing Liver-injured Mouse Model

ANIMAL MODEL FOR DRUG DEVELOPMENT

MYOSTATIN SIGNAL INHIBITOR

MODULATION OF LC3-ASSOCIATED ENDOCYTOSIS PATHWAY AND GENETICALLY MODIFIED NON-HUMAN ANIMALS AS A MODEL OF NEUROINFLAMMATION AND NEURODEGENERATION

METHOD AND DEVICE FOR DRUG SCREENING

USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG

Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith

METHODS AND MATERIALS FOR REDUCING CARDIAC XENOGRAFT REJECTION

Methods for making genetic edits

Complement Factor H Gene Knockout Rat as a Model of C3 Glomerulopathy

A GENETIC MOUSE MODEL OF AUTOIMMUNE ADVERSE EVENTS AND IMMUNE CHECKPOINT BLOCKADE THERAPY

HUMANIZED MOUSE MODEL SUSCEPTIBLE TO EMERGING CORONAVIRUSES

Novel Animal Model For Laing Distal Myopathy (Mpd1) And Methods of Use Thereof

A METHOD FOR SCREENING A THERAPEUTIC AGENT FOR CANCER USING BINDING INHIBITOR OF CYCLIN-DEPENDENT KINASE 1 (CDK1)-CYCLIN B1 AND RETINOIC ACID RECEPTOR RESPONDER 1 (RARRES1) GENE KNOCKOUT ANIMAL MODEL

PHARMACEUTICAL COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF SKIN DISEASE

EZH2- FGFR INHIBITION IN CANCER

GENE EDITING OF REPRODUCTIVE HORMONES TO REDUCE FERTILITY IN ICTALURUS PUNCTATUS

STERILE FISH

METHODS FOR PROTECTING PORCINE FETUSES FROM INFECTION WITH PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV)

Methods of treating mitochondrial disorders

Animal model of mucopolysaccharidoses type IVA

Inhibitors of alpha-tubulin acetylation for the treatment of pain

Siglec transgenic mice and methods of use thereof

COMPOSITIONS AND METHODS UTILIZING GENETICALLY-MODIFIED ANIMALS AND CELLS

TMEM100 PEPTIDES AND VARIANTS THEREOF AND THEIR USE IN TREATING OR PREVENTING DISEASES OR CONDITIONS

NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION

Genetically modified rat models for severe combined immunodeficiency (SCID)

DWARFISM ANIMAL MODEL HAVING IGF-1 GENETIC MUTATION AND METHOD FOR PRODUCING SAME

Compositions and methods for treating non-age-associated hearing impairment in a human subject

Non-human animals having a humanized lymphocyte-activation gene 3

Method for screening saltiness enhancer using saltiness receptor

Methods of using humanized FCγR mice to assay Fc regions

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS

ATOPIC DERMATITIS MODEL NON-HUMAN ANIMAL AND USE THEREOF

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS

Compositions and methods for modulating neuronal excitability and motor behavior

GENETICALLY MODIFIED SALMON WHICH PRODUCE STERILE OFFSPRING

COMPOUNDS OF CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE THEREOF

Non-human animals models of retinoschisis

Method for preparing CKO/KI animal model by using CAS9 technology

Targeted modification of rat genome

HUMAN ARTIFICIAL CHROMOSOME CONTAINING HUMAN ANTIBODY LAMBDA LIGHT CHAIN GENE AND NON-HUMAN ANIMAL CONTAINING THE HUMAN ARTIFICIAL CHROMOSOME CAPABLE OF GENETIC TRANSMISSION

Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant

Mutant Mouse-Derived Pancreatic Organoid and Method for Evaluating Standardized Drug for Efficacy

COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS

COMPOSITIONS AND METHODS FOR REGULATING MYELINATION

TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES

IMMUNODEFICIENT MOUSE

PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS RESISTANT ANIMALS

BLOOD PRODUCT DERIVED FROM GENE KNOCKOUT PIG AND USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING ENDOGENOUS IMMUNOGLOBULIN GENES AND PRODUCING TRANSGENIC HUMAN IDIOTYPE ANTIBODIES

PRODUCTION METHOD FOR ANIMAL MODELS WITH DISEASE ASSOCIATED PHENOTYPES

NON-HUMAN VERTEBRATE COMPRISING HUMAN LIVER CELLS TRANSPLANTED THEREIN AND METHOD FOR PRODUCING THE SAME

Humanized dipeptidyl-peptidase IV (DPP4) animals

T CELL REGULATION

COMMON LIGHT CHAIN MOUSE

Livestock animals with improved growth performance

Anti-Ryk antibodies and methods of using the same

COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR

ANIMAL MODEL FOR HEPATOCELLULAR CARCINOMA AND USES THEREOF

NON-MEIOTIC ALLELE INTROGRESSION

HUMANIZED HEART MUSCLE

Humanized skeletal muscle

Transgenic mouse model of Neurofibromatosis type 1

VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders

Method of making a rat model of retinal degeneration and rat model made thereby

Transgenic mouse for aglycosylated antibody production and use of aglycosylated antibody produced therefrom

Humanized knock-in mouse expressing human Protein C

Treatment for autistic spectrum disorder (ASD) and relevant symptoms

Pathogen-resistant animals having modified CD163 genes

COMPOSITIONS FOR PROLONGING THE SURVIVAL AFTER ORTHOTOPIC AND HETEROTOPIC XENOGENEIC HEART, KIDNEY, LUNG OR LIVER TRANSPLANTATIONS

IMMUNODEFICIENT NON-HUMAN ANIMAL

Non-human animals expressing humanized CD3 complex

Genetically modified non-human animals and methods of use thereof

loss of function rodent model

Liver lesion-mouse model

Multiplexed genome editing

NOVEL IMMUNODEFICIENT RAT FOR MODELING HUMAN CANCER

Double knockout (GT/CMAH-KO) pigs, organs and tissues

ADAM6 KNOCKIN MICE

IMMUNORECEPTOR MODULATION FOR TREATING CANCER AND VIRAL INFECTIONS

INDUCIBLE DISEASE MODELS METHODS OF MAKING THEM AND USE IN TISSUE COMPLEMENTATION

Mutations in rhodopsin gene in zebrafish and uses thereof

METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATIONS AND METHODS OF USE

MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE

EMBRYONIC ZEBRAFISH MODELS USING DNAZYME MEDIATED KNOCKDOWN

Reelin antibodies for treatment of atherosclerosis

NOVEL NUCLEIC ACID CONSTRUCT

COMPOSITION FOR GENE THERAPY OF THE CENTRAL NERVOUS SYSTEM, PROCESS OF PRODUCTION AND USE THEREOF

CRISPR/Cas9 vector combination and application thereof in gene knockout

Development of superior chimerism by hiPSC engineering and embryo aggregation

Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements

MODELING TDP-43 PROTEINOPATHY

MATERIALS AND METHODS FOR PREVENTING TRANSMISSION OF A PARTICULAR CHROMOSOME

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS

Animal Models and Therapeutic Molecules

CONSTRUCTION METHOD FOR ANIMAL MODEL FOR RETINITIS PIGMENTOSA DISEASES AND APPLICATION

MRGPRX2/MRGPRB2 EXPRESSING CELL BASED ASSAY TO DETECT PSEUDO-ALLERGIC DRUG REACTIONS AND TO IDENTIFY BLOCKERS TO PREVENT THE ADVERSE REACTIONS

Factor VII Composition Having a Substantially Homogeneous Isoelectric Point

Motor neuron-specific expression vectors

Animal Models and Therapeutic Molecules

Animal Models and Therapeutic Molecules

TIE2 RECEPTOR ACTIVATION FOR GLAUCOMA

Genetically modified non-human animals and methods for producing heavy chain-only antibodies

Animal Models and Therapeutic Molecules

Large animal model for developing therapeutic agents to treat impaired ophthalmic function in usher syndrome

Method for preparing porcine fibroblasts with both CD163 gene and CD13 gene being knocked-out

METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY

Transgenic chicken comprising an inactivated immunoglobulin gene

Methods and compositions for the targeted modification of a genome

LOSS OF FUNCTION RODENT MODEL OF SOLUTE CARRIER 39 MEMBER 5

Humanized non-human animals with restricted immunoglobulin heavy chain loci

Non-human animals expressing humanized CD3 complex

GENERATION AND CORRECTION OF A HUMANIZED MOUSE MODEL WITH A DELETION OF DYSTROPHIN EXON 44

Factor VII composition having a substantially homogenous isoelectric point

ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MUCOLIPIDOSIS TYPE II

EXON DELETION CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS IN THE DYSTROPHIN ACTIN BINDING DOMAIN 1 USING CRISPR GENOME EDITING

NANOS knock-out that ablates germline cells

FISH AND METHOD FOR PRODUCING FISH

P21-Activated Kinase Inhibitor Domain Targeted Transgenic Mouse

HUMAN ARTIFICIAL CHROMOSOME CONTAINING HUMAN ANTIBODY LAMBDA LIGHT CHAIN GENE AND NON-HUMAN ANIMAL CONTAINING THE HUMAN ARTIFICIAL CHROMOSOME CAPABLE OF GENETIC TRANSMISSION

SIGNATURES AND DETERMINANTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION AND METHODS OF USE THEREOF

CELLS, VERTEBRATES, POPULATIONS & METHODS

Transgenic Animals

Cell therapy with lentiviral transduced CSF2RA transgene in the treatment of hereditary pulmonary alveolar proteinosis

Nuclease-mediated repeat expansion

MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

Mouse with cholinergic neuron-specific inactivated ANO1 gene

METHOD FOR CONSTRUCTING MOUSE MODEL WITH CONDITIONAL KNOCKOUT OF TMEM30A GENE FROM PANCREATIC BETA CELL, AND USE THEREOF

Multiplexed genome editing

USE OF CREG IN TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES

Porcine reproductive and respiratory syndrome virus resistant animals